The Apo-1/Fas antigen (CD95) mediates programmed cell death of lymphocytes when bound by Fas ligand or anti-Apo-1/Fas antibody. In contrast, the CD40 antigen provides a potent activation and survival signal to B lymphocytes when it is engaged by its T cell ligand (CD40L, gp39) or cross-linked by anti-CD40 antibody. In this study, we use human tonsillar B cells and the Ramos Burkitt's lymphoma B cell line, which serves as a model for human germinal center B lymphocytes, to study the effectors of Apo-1/Fas expression and apoptosis of human B cells. We found that Apo-1/Fas expression was upregulated on both malignant and normal human B lymphocytes after CD40 ligation induced by (a) cognate T helper-B cell interaction mediated by microbial superantigen (SAg); (b) contact-dependent interaction with CD40L +, but not CD40L-Jurkat mutant T cell clones; and (c) monoclonal anti-CD40, but not any of a panel of control antibodies. Enhanced B cell Fas/Apo-1 expression is functionally significant. Coculture of Ramos Burkitt's lymphoma line cells with irradiated SAg-reactive CD4 + T cells with SAg or CD40L + Jurkat T cells results in B cell apoptosis, evidenced by reduced cell viability and DNA laddering. This process is augmented by the addition ofanti-Apo-1/Fas monoclonal antibody, consistent with an acquired susceptibility to Apo-1/Fas-mediated apoptosis. These data support an immunoregulatory pathway in which seemingly contradictory signals involving the B cell proliferation/survival antigen CD40, as well as the Apo-1/Fas molecule, which mediates programmed cell death oflymphocytes, are linked in the process of human B cell activation.
Summary
The Apo-1/Fas antigen (CD95) mediates programmed cell death of lymphocytes when bound by Fas ligand or anti-Apo-1/Fas antibody. In contrast, the CD40 antigen provides a potent activation and survival signal to B lymphocytes when it is engaged by its T cell ligand (CD40L, gp39) or cross-linked by anti-CD40 antibody. In this study, we use human tonsillar B cells and the Ramos Burkitt's lymphoma B cell line, which serves as a model for human germinal center B lymphocytes, to study the effectors of Apo-1/Fas expression and apoptosis of human B cells. We found that Apo-1/Fas expression was upregulated on both malignant and normal human B lymphocytes after CD40 ligation induced by (a) cognate T helper-B cell interaction mediated by microbial superantigen (SAg); (b) contact-dependent interaction with CD40L +, but not CD40L-Jurkat mutant T cell clones; and (c) monoclonal anti-CD40, but not any of a panel of control antibodies. Enhanced B cell Fas/Apo-1 expression is functionally significant. Coculture of Ramos Burkitt's lymphoma line cells with irradiated SAg-reactive CD4 + T cells with SAg or CD40L + Jurkat T cells results in B cell apoptosis, evidenced by reduced cell viability and DNA laddering. This process is augmented by the addition ofanti-Apo-1/Fas monoclonal antibody, consistent with an acquired susceptibility to Apo-1/Fas-mediated apoptosis. These data support an immunoregulatory pathway in which seemingly contradictory signals involving the B cell proliferation/survival antigen CD40, as well as the Apo-1/Fas molecule, which mediates programmed cell death oflymphocytes, are linked in the process of human B cell activation.
Po-1/Fas (CD95) is a 48-kD cell surface antigen of the TNF/nerve growth factor (NGF) 1 receptor superfamily that mediates apoptosis of T and B lymphocytes (1) . The interaction of Apo-1/Fas and its ligand have been shown to play a central role in the regulation of programmed cell death of mature peripheral murine and human T lymphocytes. Defects in both Fas and its ligand have been described in murine models of lymphoproliferative disease characterized by features of SLE (2) (3) (4) , suggesting that this pathway may be responsible for the deletion ofautAbbreviations used in this paper: CD40L, CD40 ligand; MAM, Mycoplasma arthritidis-derived microbial superantigen; MHC II, MHC class II; NGF, nerve growth factor; SAg, microbial superantigen; TSST-1, toxic shock syndrome toxin 1; TMAMxr, irradiated MAM-reactive CD4 § cells; TTSSTxF, TSST-l-reactive CD4 + cells. toreactive clones. In peripheral T lymphocytes, TCR signaling leads to upregulation of Apo-1/Fas and, on Thl cells, Fas ligand expression, resulting in fratricide or even suicide of antigen-activated T cells (5) (6) (7) (8) . Although Apol/ Fas expression occurs early after antigen stimulation, susceptibility to Apo-1/Fas-mediated apoptosis develops slowly (9) , allowing for the clonal expansion and effector function of antigen-activated T cells before their apoptotic elimination. B lymphocytes also express the Apo-1/Fas receptor (10, 11), and they are induced to undergo apoptosis when bound by Fas ligand, which is secreted selectively from Thl cells (12, 13) . The observations that the mAb to human Apo-1/Fas can induce apoptosis of B lymphoblastoid tumor cells in vitro (14) and ofxenografted human B cell tumors in vivo (15) suggest that the Apo-1/Fas signal-ing pathway may function in the immunosurveillance of B cell tumors.
The CD40 antigen is a 50-kD cell surface protein, also of the TNF/NGF receptor superfamily, which promotes B cell proliferation and survival. Germinal center B cells can be rescued from spontaneous apoptosis in vitro by soluble anti-CD40 mAb (16) . When engaged by the T cell activation molecule CD40L (gp39) or when cross-linked by anti-CD40 antibody, CD40 induces a potent B cell activation signal (17, 18) that is characterized by expression of activation antigens (19, 20) , increased DNA synthesis (21) , tyrosine kinase activity (22) , and Ig class switching (23) (24) (25) .
The need to control the magnitude and duration of humoral immune responses after antigenic stimulation suggests that the pathways of B cell activation and apoptosis may be closely linked. In this study, we demonstrate that cognate Th-B cell interaction mediated by CD40 ligation leads to marked upregnlation of Apo-1/Fas expression on normal and malignant human B lymphocytes. Using the Burkitt's lymphoma Ramos B cell line as a model of germinal center B cells (26, 27) , we demonstrate that this interaction both upregnlates Apo-1/Fas expression and facilitates susceptibility to Apo-1/Fas-mediated programmed cell death.
Materials and Methods
Cell Culture. B cells were isolated from fresh human tonsils as described previously (28) . Briefly, T cells were eliminated by rosetting overnight with SRBCs, and the isolated B cell population was frozen in liquid nitrogen and cryopreserved at -70~ B cells were thawed, washed, and cultured in C50 medium (RPMI 1640 medium with penicillin, streptomycin, glutamine, and 10% fetal bovine serum). The Burkitt's lymphoma Ramos B cell line was obtained from American Type Culture Collection (Rockville, MD) and grown in C50 as described above. Mutant clones of the Jurkat lymphoblastoid T cell lines B2.7 and D1.1 were kindly provided by Dr. Seth Lederman (Columbia University College of Physicians and Surgeons, New York, NY). B2.7 is deficient in CD40L expression, while clone D1.1 constitutively expresses CD40L (17, 29) , which were confirmed by staining with antibody to CD40L (Genzyme Corp., Cambridge, MA). As indicated, cells were cultured in the presence of highly purified Mycoplasma arthritidis-derived microbial superantigen (SAg) (MAM) at a final concentration of 1:80,000 of stock solution, which was generously provided by Dr. B. Cole (University of Utah College of Medicine, Salt Lake City, UT) (30), or toxic shock syndrome toxin-1 (TSST-1) at a final concentration of 10 ng/ml (Toxin Technology, Sarasota, FL).
Coculture experiments were performed using 106 B cells and 2 • 105 irradiated MAM-or TSST-l-reactive CD4 + cells (TM^M• or TrssTxr, respectively), or with Jurkat T cells (B2.7xr or Dl.l• in a final volume of 1 ml C50 media. After irradiation with 500 (SAg-reactive T cells) or 1,000 rads (Jurkat mutants), the T cells were still functional in cognate interaction, as assessed by CD23 and Apo-1/Fas induction on the B cells, but they died in culture within 24- mAbs. Sterile antibodies used in cell culture experiments include anti-human Fas (murine IgM; Upstate Biotechnology Inc., Lake Placid, NY) used at 100 ng/ml, and anti-CD40 (mouse IgGIK, clone B-B20; Biosource International, Camarillo, CA), anti-CD40L (Genzyme), anti-CD71 (anti-transferrin receptor, mouse IgG~; Biosource), anti-CD54 (anti-ICAM; AMAC Inc., Westbrook, ME), and anti-CD37 (mouse IgG2a; Biosource), W6/32 (anti-MHC I), NAMBI (anti-i32-microglobulin), and L-243 (anti-MHC class II [MHC II]; gift of Dr. Carlo Russo, Cornell University Medical College), OKT3 (mouse IgG2a; ATCC), anti-CD20 (PharMingen, San Diego, CA), and anti-CD23 IgG (EBVCS2; ATCC) or anti-CD23 IgM (EBVCS3; ATCC). For culture, these antibodies were used at 1 ~zg/ml unless otherwise specified. Directly conjugated antibodies used in cell staining experiments include anti-Apo-l-biotin (IgG3K) or anti-Apo-l/Fas-FITC (IgG1; Immunotech, Inc., Westbrook, ME), B1 (Coulter Immunology, Hialeah, FL), anti-CD19-FITC (PharMingen), and anti-CD4-biotin (PharMingen). For blocking experiments, an F(ab)'2 preparation of the anti-Apo-I lgG3K antibody was used at 200 ng/ml (5) .
Indirect Immunofluorescence Analysis. Cells were washed in cold HBSS and stained in primary antibodies (or control, 1% BSA in PBS with azide) for 45 min at 4~ Cells were washed 35< in cold HBSS, incubated with secondary antibodies or FITC-avidin, as indicated, for 25 rain at 4~ and then washed 3• again in cold HBSS. Alternatively, cells were washed in cold HBSS and stained with a single, directly conjugated primary antibody before washing 3• before analysis. Cell fluorescence was analyzed on a FACScan | (Becton Dickinson) and analyzed with CellQuest (Becton Dickinson).
Superantigen-reactive CD4 + T Cell Lines. As described previously (29) , PBL from normal donors were cultured at 2 X 10r in the presence of highly purified MAM at a final dilution of 1 : 80,000 or TSST-1 at a final concentration of 10 ngm/ml. After 3 d, the cultures were supplemented with human IL-2 (Schiapparelli, Columbia, MD), and 1 d later, blast and resting cells were separated by Ficoll gradient centrifugation. Purified CD4 + T cells were obtained by immune rosette depletion ofCD8 + cells. These CD4 +, SAg-reactive, T cell lines (TMA M or TTSST ) were frozen -70~
After thawing and washing, they were grown in the presence of IL-2, and periodically expanded by retriggering with the relevant SAg in the presence of irradiated, autologous non-T cells.
Viability Assay. Aliquots of cultured cells were diluted ] :4 in 0.4% trypan blue and were analyzed for the exclusion of dye by light microscopy.
DNA Analysis. After 2 d of culture with irradiated CD4 + T cells, viable B cell populations were purified by Ficoll Hypaque centrifugation. These cells were cultured for an additional 16 h in the presence of media alone, anti-Apo-1/Fas IgM or anti-CD23 IgM at a concentration of 200 ng/ml. Low molecular weight DNAs prepared from 106 cells by lysis in 20 I.~1 buffer (10 mM EDTA, 50 mM Tris-C1, pH 8.0, 0.5% SDS, 0.5 mg/ml proteinase K) at 50~ for 1 h, followed by the addition ofRNAse A (0.5 mg/ml) at 50~ for 1 h. After heating (70~ 5 min), DNAs were analyzed by 1.6% agarose gel electrophoresis in the presence of ethidium bromide (0.16 ~g/ml), and they were photographed under UV light. (Fig. 1 A) . As shown in Fig. 1 B, this effect is specific, since TSST-reactive CD4 § T cells are effective in upregulating Apo-1/Fas expression only in the presence of TSST-1, and not when non-cross-reactive SAg (MAM) is present in the culture system.
Results

Cognate Th-B Cell Interactions Upregulate Apo-I /Fas Expression on Human
To study the effect o f cognate T -B cell interaction on Apo-1/Fas expresssion in a more homogeneous target B cell population, we focused on the Burkitt's lymphoma P.amos B cell line. Burkitt's lymphoma cell lines such as k a m o s bear phenotypic and functional similarities to human germinal center B cells (26, 27) . As shown in Fig. 2 , although there was modest upregulation of Apo-1/Fas when the B cells were cultured with SAg-reactive CD4 + T cells alone, Apo-1/Fas expression was dramatically increased on Ramos B cells cultured with both M A M and TMAMxr.
Apo-I /Fas Expression on B Cells Is Facilitated by the Interaction of CD40 with Its T Cell Ligand, CD4OL. Cognate
T h -B cell interaction is mediated, in large measure, by signals delivered to the B cell by the CD40 antigen (17) . To investigate the role of CD40 ligation in T cell-induced B cell Apo-1/Fas expression, we used two well-characterized mutant clones of the Jurkat T cell line (17, 29) . Clone D 1.1 cells constitutively express high levels of gp39, the physiologic ligand of CD40 (CD40L), while clone B2.7 is deficient in CD40L expression. As shown (Fig. 3 (Table 1) .
T o assess the requirement for cell-cell contact in this response, t w o -c h a m b e r experiments were performed in , lanes 1-3) or CD40L + (Dl.l~r, lanes 4-6)Jurkat mutants, with CD4 + TMAMx r without (lanes 7-9), or with (lanes I0 and 11) MAM. After Ficoll Hypaque centrifugation, viable IKamos B cells were cultured overnight after the addition of media (1, 4, 7) , anti-Apo-1 mAb (2, 5, 8, 10), or anti-CD23 (3, 6, 9, 11) , each at a concentration of 200 ng/ml, and low molecular weight DNAs were prepared and analyzed by ethidium bromide agarose gel electrophoresis. Molecular weight markers are indicated. grammed cell death of lymphocytes are linked in the process of human B cell activation. Productive B cell activation requires the delivery of at least two signals, the binding of antigen to surface Ig receptors (signal 1), followed by cognate interaction with an antigen-specific T cell (signal 2) (34, 35) . The studies reported here suggest that in the absence of slg signaling, B cells stimulated via CD40 upregulate Apo-1/Fas and are prepared for the delivery of death signals. This pathway could serve to eliminate bystander B cells that are inappropriately activated. Presumably, a B cell that has received both signals 1 and 2 would be resistant to this form of elimination and respond by proliferation and differentiation into an antibody-forming cell. Consistent with this hypothesis, we have determined that cross-linking of surface Ig on Ramos B cells by anti-IgM antibody does not affect Apo-1/Fas expression induced by CD40 ligation, but does render these cells resistant to apoptosis (Schattner, E., unpublished data).
The results described in this study must be considered in the context of previous reports from our laboratories and others that direct T cell help for B cell activation mediated by allospecific T cell lines or SAg-induced Th-B cell bridge can result in polyclonal activation of both human and murine B cells (29, (36) (37) (38) . Heterogeneity in the response of B cell subpopulations to CD40 ligation may be a factor in determining the outcome of the Th-B cell interaction. For example, it is the high density, resting B cell subset that expresses the activation antigen CD23 in re-sponse to cognate Th-B cell interaction (39) . An additional determinant of the B cell's fate may be the relative abundance of Thl and Th2 cells in culture. Thl cells secrete cytokines central to the cellular immune response, such as IL-2 and IFN-~/(40), and they selectively express Fas ligand after activation (12) , while CD4 + Th2 cells secrete cytokines that support the humoral immune response. A role for CD4 + Thl cells in Apo-1/Fas-mediated B celt death is consistent with this functional dichotomy, and it supports a mechansim other than antagonistic cytokine effects by which Thl cells can downregulate B cell responses. The association of defects in the Fas/Apo-1/Fas ligand pair in the development of SLE-like disease in several strains of mice (2) (3) (4) suggests that this pathway may be involved in the control of autoreactive B cells. SAg-mediated, CD4 + T cell-induced B cell apoptosis should provide a model system for assessing the integrity of this signaling pathway in human SLE.
Our data suggest a possible mechanism for the development of B cell lymphomas in patients with X-linked hyper-IgM, an immunodeficiency syndrome defined by molecular defects in the T cell ligand for CD40 (41, 42) . In these patients, impaired signaling through CD40 might allow for uncontrolled B cell expansion due to a lack of CD40L-mediated upregulation of Apo-1/Fas on B cells. This signahng pathway, which primes B cells for CD4 + cell-mediated B cell apoptosis, may also relate to the high incidence of B cell lymphomas among patients with HIV disease, where a high proportion of tumors are of Burkitt's or Burkitt's-like (small, noncleaved cell) subtypes (43) , similar to those of the Ramos B cell line used in our experiments. In HIV disease, the progressive decline of CD4 + T cells would diminish the capacity for Apo-1/Fas induction on B cells via the CD40L T cell-dependent pathway we have described. Moreover, the reduction ofCD4 + T cells and shift from a Thl-to Th2-dominant population would specifically deplete the host of those T cells that express and secrete human Fas ligand and are responsible for Fas-mediated B cell cytotoxicity. In that setting, B cell malignancies would arise due to a lack of CD4 + T cell-mediated induction of Apo-1/Fas, with subsequent failure orB cell apoptosis. This work was supported by the Dorothy Rodbell Cohen Foundation for Sarcoma Research (E. Schattner) and a National Institutes of Health grants AI32634 and P50AR 42588 (Specialized Center of Research in Systemic Lupus Erythematosus).
